Linnemann, B <br/><br/>
Alteration of pharmacokinetics of lepirudin caused by anti-lepirudin antibodies occurring after long-term subcutaneous treatment in a patient with recurrent VTE due to Behcets disease.  [electronic resource] 

 -  VASA. Zeitschrift fur Gefasskrankheiten  Feb 2010 
 - 103-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0301-1526 
<br/><br/><label>Standard No.: </label>10.1024/0301-1526/a000012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies--blood<br/>Anticoagulants--adverse effects<br/>Behcet Syndrome--complications<br/>Dose-Response Relationship, Drug<br/>Female<br/>Heparin--therapeutic use<br/>Hirudins--adverse effects<br/>Humans<br/>Recombinant Proteins--adverse effects<br/>Recurrence<br/>Venous Thromboembolism--drug therapy